Severe Hearing Loss in the Aging Population Poses a Global Public Health Challenge. How Can We Better Realize the Benefits of Cochlear Implantation to Mitigate This Crisis?
Overview
Affiliations
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss.
Lutze R, Ingersoll M, Kelmann R, Teitz T Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931403 PMC: 11206450. DOI: 10.3390/ph17060735.
Lutze R, Ingersoll M, Kelmann R, Teitz T bioRxiv. 2024; .
PMID: 38826449 PMC: 11142120. DOI: 10.1101/2024.05.20.595056.
[Cochlear implantation in Senegal: challenges, limits and perspectives].
Lame C, Sy A, Loum B Pan Afr Med J. 2023; 45:12.
PMID: 37426468 PMC: 10323811. DOI: 10.11604/pamj.2023.45.12.39881.
Comprehensiveness of online sources for patient education on hereditary hearing impairment.
Duymaz Y, Tekin A, DHaese P, Sahin S, Erkmen B, Cirik A Front Pediatr. 2023; 11:1147207.
PMID: 37404560 PMC: 10315533. DOI: 10.3389/fped.2023.1147207.
Evaluation of a Less Invasive Cochlear Implant Surgery in Mutations Provoking Deafblindness.
Tekin A, Baelen H, Heuninck E, Bayazit Y, Mertens G, Van Rompaey V Genes (Basel). 2023; 14(3).
PMID: 36980899 PMC: 10048538. DOI: 10.3390/genes14030627.